Miltenyi Biotec and ShareLab invite the local science community to an afternoon dedicated to Cell Therapy and Immuno-oncology. Our CSO, Hugh Salter, will join this event and present Anocca’s platform for scaleable TCR-T cell therapy development.

< Back to newsroom